COMMUNIQUÉS West-GlobeNewswire

Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment
23/03/2026
March 23, 2026 John DeFord proposed as new member of the Supervisory Board. Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board. Marc Harrison will step down [...]
Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer
23/03/2026
BASEL, Switzerland, March 23, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with precision biologics, announces today the appointment of Thaminda [...]
Amphista Therapeutics announces three presentations at the American Association for Cancer Research Annual Meeting on its next-generation Targeted Glue™ degrader programs
23/03/2026
Cambridge, UK, 23 rd March 2026 – Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces three upcoming [...]
Groundbreaking Danish research project launches to cure Parkinson’s disease
23/03/2026
A new research project aims to develop the world’s first therapy to eliminate and prevent the spread of a toxic brain protein that drives Parkinson’s disease. Innovation Fund Denmark has invested DKK 26,689,872million [...]
Persica Pharmaceuticals Appoints Dr Edward Littler as Executive Chairman and David Watson as Chief Executive Officer
23/03/2026
New senior executives bring significant biopharma experience as Persica moves to next phase of its development London, UK, 23 March 2026 - Persica Pharmaceuticals Limited (Persica), a clinical stage biotechnology [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
23/03/2026
COPENHAGEN, Denmark, March 23, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on March 12, 2026, under which the Company will repurchase shares for an amount up [...]
Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 – World’s Premier Cancer Research Forum
23/03/2026
Accepted Abstracts Highlight Advances in AI-Driven Oncology Pipeline VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO0), a biopharmaceutical company [...]
Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026
23/03/2026
New Rhapsido ® REMIX-1 & -2 pooled analysis on symptom control as early as week 1 in chronic spontaneous urticaria (CSU) to be presented Long-term Cosentyx ® data build on extensive body of evidence supporting [...]
CoaguSense Announces Agreement to Acquire DOASENSE DOAC Testing Business, Expanding Leadership in Anticoagulation Monitoring
23/03/2026
FREMONT, Calif., March 22, 2026 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a leading developer of point-of-care coagulation monitoring systems and a subsidiary of i-SENS, Inc. (KOSDAQ: 099190), today announced it has entered [...]
Basilea announces start of first‑in‑human study of novel antibiotic BAL2420
23/03/2026
Allschwil, Switzerland, March 23, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal [...]
ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update
23/03/2026
EINDHOVEN, the Netherlands, March 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and [...]
HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China
23/03/2026
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a registrational Phase III [...]
INB.bio Launches 2026 Growth Strategy With New Market Entries Across Africa, MENA and Southeast Asia
23/03/2026
The direct advertiser and wellness infrastructure company targets five new countries as global wellness demand accelerates in emerging markets BERLIN, March 22, 2026 (GLOBE NEWSWIRE) -- Global demand for wellness [...]
Apogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026
23/03/2026
Webcast to be held Monday, March 23rd at 8:00 a.m. ET SAN FRANCISCO and BOSTON, March 22, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, [...]
Akemi Hair Glow Claims Evaluated: 2026 Hair Growth Transparency Report Examines DHT-Blocking Spray Research, "56% Thicker Hair" Data, and Ingredient Research for Women
22/03/2026
A 2026 informational report presenting Akemi Hair Glow's DHT-blocking claims alongside ingredient-level research context, topical delivery positioning, pricing structure, and key verification factors for consumers [...]
L'IBA lance myQA MatriXX AiR et fait évoluer l'assurance qualité spécifique des patients en thérapie par particules
21/03/2026
La première gamme de chambres d'ionisation sans fil pour la thérapie par particules, PSQA, fournissant une vérification rapide et fiable des traitements par protons et ions carbone, et adaptée aux techniques émergentes [...]
IBA Launches myQAMatriXXAiR to Advance Patient‑Specific QA in Particle Therapy
21/03/2026
The first wireless ionization chamber array for particle therapy PSQA delivers fast, reliable verification for proton and carbon ion treatments, supporting emerging techniques such as FLASH and ARC radiotherapy. Louvain [...]
Financière de Tubize - Rapport annuel 2025
21/03/2026
Rapport annuel 2025 Informations réglementées - 21 mars 2026 Le conseil d’administration de la Financière de Tubize a établi le rapport annuel 2025. Ce rapport est disponible sur le site internet www.financiere-tubize. [...]
Financière de Tubize - Annual report 2025
21/03/2026
Annual Report 2025 Regulated information 21 March 2026 The board of directors of Financière de Tubize has established the 2025 annual report. This report is available on the website www.financiere-tubize.be Profit for [...]

Pages